Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)

University of Erlangen-Nürnberg1 site in 1 country30 target enrollmentApril 2009

ConditionsPrimary Open Angle Glaucoma Secondary Open Angle Glaucoma Due to PEX

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Primary Open Angle Glaucoma
Sponsor: University of Erlangen-Nürnberg
Enrollment: 30
Locations: 1
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring contrast sensitivity. No therapeutic studies are performed.

Registry

clinicaltrials.gov

Start Date

April 2009

End Date

TBD

Last Updated

16 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University of Erlangen-Nürnberg

Eligibility Criteria

Inclusion Criteria

•Age \> 18
•Best corrected visual acuity 0.8 or better

Exclusion Criteria

•eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich are not due to PEX, diseases involving retina, condition after ophthalmological operations or trauma, cataract, diseases concerning the refractive system, age-related macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia
•Any neurological diseases
•Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)
•Systemic drugs with potentially ocular involvement
•ocular drugs